Apimeds Pharmaceuticals US appoints Sungjoon Chae to board
Apimeds Pharmaceuticals US said Sungjoon Chae joined its board effective Sept. 10, 2026. It also said he has served as co-chief executive officer since May 4, 2026.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.